Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Operating expenses
Research and development	$ 1,423,359	$ 955	$ 2,188,849	$ 295,150
General and administrative	1,053,481	511,336	3,951,021	1,612,803
Total operating expenses	2,476,840	512,291	6,139,870	1,907,953
Loss from operations	(2,476,840)	(512,291)	(6,139,870)	(1,907,953)
Other income (expense)
Gain on remeasurement of warrant liabilities	200,273	0	1,312,899	0
Interest and other income (expense), net	(547)	0	(3,948)	25,004
Interest expense	0	(146,250)	0	(375,187)
Total other income (expense), net	199,726	(146,250)	1,308,951	(350,183)
Loss before provision for income taxes	(2,277,114)	(658,541)	(4,830,919)	(2,258,136)
Provision for income taxes	2,102	547	6,004	1,347
Net loss	$ (2,279,216)	$ (659,088)	$ (4,836,923)	$ (2,259,483)
Net loss per share:
Basic and diluted (in dollars per share)	$ (0.12)	$ (0.24)	$ (0.36)	$ (0.82)
Weighted average shares outstanding Basic and diluted (in shares)	18,455,586	2,775,127	13,554,548	2,770,623